Norman Michael Greenberg
No más puestos en curso
Perfil
Norman Michael Greenberg is currently a Director at Mongoose Bio, Inc. He was previously the Chief Scientific Officer at Atreca, Inc. from 2016 to 2021, Vice President-Global Research at Medimmune, Inc. from 2011 to 2014, Senior Vice President-Translational Medicine at Checkmate Pharmaceuticals, Inc. from 2015 to 2016, and President & Chief Executive Officer at NMG Scientific Consulting USA from 2014 to 2016.
He also held positions as a Senior Director-Research at Pfizer Inc. from 2009 to 2011 and an Associate Professor at Baylor College of Medicine from 1998 to 2003.
Dr. Greenberg is a doctorate graduate from the University of British Columbia and an undergraduate graduate from the University of Toronto.
Cargos activos de Norman Michael Greenberg
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de Norman Michael Greenberg.
| Empresas | Cargo | Fin |
|---|---|---|
| ATRECA, INC. | Director Técnico/Científico/I+D | 31/03/2021 |
| CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2016 |
| NMG Scientific Consulting USA | Director Ejecutivo | 01/05/2016 |
| Medimmune, Inc. | Director Técnico/Científico/I+D | 01/05/2014 |
| PFIZER, INC. | Director Técnico/Científico/I+D | 01/07/2011 |
Formación de Norman Michael Greenberg.
| University of British Columbia | Doctorate Degree |
| University of Toronto | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ATRECA, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Commercial Services |
| Medimmune, Inc. | Health Technology |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
| NMG Scientific Consulting USA |
- Bolsa de valores
- Insiders
- Norman Michael Greenberg
